Clinical trial
Prospective, Multicentric, Randomized Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
NCT05039606 is registered in ClinicalTrials.gov with Guiyang Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicentric, Randomized Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
- Lead sponsor
- Guiyang Medical University
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 30, 2021
- Completion date
- September 30, 2026
- Enrollment
- 164 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck squamous carcinoma